Adlon Therapeutics L.P. To Provide Funding Opportunities for Research to Expand Understanding of ADHD

Adlon Therapeutics L.P. Announces FDA Approval for Adhansia XR™ (Methylphenidate HCL) Extended-release Capsules CII for the Treatment of ADHD